This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The new online Learning Center with new content can still be found under the “Training” folder on ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...